Spots Global Cancer Trial Database for venous thromboembolism
Every month we try and update this database with for venous thromboembolism cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) | NCT03099031 | Venous Thromboe... | Tinzaparin | 18 Years - | LEO Pharma | |
| A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | NCT05171075 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Dalteparin | 18 Years - | Anthos Therapeutics, Inc. | |
| A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use | NCT02922543 | Multiple Myelom... | 18 Years - | Celgene | ||
| Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients | NCT04301362 | Cancer Thromboembolism Thrombosis Biomarkers | Thrombosis biom... | 18 Years - | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | |
| Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort Study | NCT04588805 | Incidence Rate ... | - | Beijing Friendship Hospital | ||
| Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma | NCT00192829 | Non-Small Cell ... Venous Thromboe... | Blood sample wi... | - | Rambam Health Care Campus | |
| Anticoagulation Length in Cancer Associated Thrombosis | NCT01817257 | Cancer Thrombosis Venous Thromboe... Deep Vein Throm... Pulmonary Embol... | Low Molecular W... | 16 Years - | Cardiff University | |
| Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism | NCT01164046 | Venous Thromboe... Neoplasms | low molecular w... vitamin K antag... | 18 Years - | University Medical Center Groningen | |
| Optimal Prophylactic Method of Venous Thromboembolism (VTE) | NCT01448746 | Venous Thromboe... | low molecular w... | 20 Years - 75 Years | The Catholic University of Korea | |
| Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy | NCT04352439 | Venous Thromboe... Ovarian Cancer | Aspirin | 18 Years - | Duke University | |
| Hemostatic Profiles of Endocrine Therapies for Breast Cancer | NCT03381963 | Breast Neoplasm... Venous Thromboe... | 18 Years - | University Hospital, Geneva | ||
| WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism | NCT03297359 | Cancer Venous Thromboe... Obesity | Dalteparin | 18 Years - | Ottawa Hospital Research Institute | |
| Screening for Occult Malignancy in Idiopathic Venous Thromboembolism | NCT00361647 | Venous Thromboe... | Diagnostic scre... | 18 Years - | University of Padova | |
| Venous Thromboembolic Complications in Ovarian Cancer | NCT02480790 | Venous Thromboe... Ovarian Neoplas... Ovarian Cancer Deep Vein Throm... Lung Embolism | 18 Years - 100 Years | Aalborg University Hospital | ||
| Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients | NCT00966277 | Pancreatic Canc... Venous Thromboe... | Dalteparin | 18 Years - | M.D. Anderson Cancer Center | |
| Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin | NCT04999176 | Cancer Rivaroxaban Venous Thromboe... Thromboprophyla... | Rivaroxaban Enoxaparin | 18 Years - 89 Years | Science Valley Research Institute | |
| Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer | NCT01130025 | Venous Thromboe... | Warfarin Innohep® | 18 Years - | LEO Pharma | |
| Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias. | NCT03405571 | Multiple Myelom... Venous Thromboe... | No intervention | 18 Years - | University of Athens | |
| Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study | NCT05229471 | Cancer Venous Thromboe... Recurrence | 18 Years - 120 Years | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | ||
| Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection | NCT03115541 | Venous Thromboe... Thoracic Surger... Esophageal Canc... | 18 Years - | McMaster University | ||
| Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism | NCT02017743 | Venous Thromboe... | 18 Years - | Trio Grup Clinical Research | ||
| Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study | NCT06284343 | Cancer-associat... Venous Thromboe... Gynecologic Can... Ovarian Cancer Cervix Cancer Endometrial Can... Vaginal Cancer | Anticoagulant | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Hemostatic Profiles of Endocrine Therapies for Breast Cancer | NCT03381963 | Breast Neoplasm... Venous Thromboe... | 18 Years - | University Hospital, Geneva | ||
| Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy | NCT00694382 | Venous Thromboe... Cancer | Semuloparin sod... Placebo (for se... | 18 Years - | Sanofi | |
| Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients | NCT00135876 | Venous Thromboe... Brain Tumors | dalteparin | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | NCT05171049 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Apixaban | 18 Years - | Anthos Therapeutics, Inc. | |
| Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients | NCT00952380 | Venous Thromboe... | dalteparin | - 18 Years | Pfizer | |
| CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) | NCT00219973 | Cancer Venous Thromboe... | Bemiparin | 40 Years - | Rovi Pharmaceuticals Laboratories | |
| Thromboprophylaxis After Surgery for Gynecologic Malignancy in China | NCT02935530 | Gynecologic Neo... Venous Thromboe... Low Molecular W... Argatroban | s-LMWH LMWH Argatroban | 16 Years - 70 Years | Huazhong University of Science and Technology | |
| Venous Thromboembolic Complications in Ovarian Cancer | NCT02480790 | Venous Thromboe... Ovarian Neoplas... Ovarian Cancer Deep Vein Throm... Lung Embolism | 18 Years - 100 Years | Aalborg University Hospital | ||
| Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care | NCT00303407 | Cancer Venous Thromboe... | nadroparin | 0 Years - | University Hospital, Geneva | |
| Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer | NCT02744092 | Cancer Venous Thromboe... Deep Vein Throm... Pulmonary Embol... Blood Clot | Rivaroxaban Apixaban Edoxaban Dabigatran Warfarin Dalteparin Enoxaparin Fondaparinux | 18 Years - | Alliance Foundation Trials, LLC. | |
| Venous Thromboembolism in Advanced Lung Cancer | NCT03581708 | Lung Neoplasms Venous Thromboe... | lung cancer | 18 Years - | Guangdong Provincial People's Hospital | |
| Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer | NCT00981903 | Venous Thromboe... Cancer | Tinzaparin sodi... | 18 Years - | University of Southern California | |
| Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer | NCT00476216 | Non-Small Cell ... Venous Thromboe... | Combination of ... | 18 Years - 79 Years | University of Alabama at Birmingham | |
| Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients | NCT00952380 | Venous Thromboe... | dalteparin | - 18 Years | Pfizer | |
| A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors | NCT01325558 | Locally Advance... Malignant Solid... | ALT-836 in comb... | 18 Years - | Altor BioScience | |
| Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer | NCT05240508 | Venous Thromboe... | 18 Years - | University of Vermont | ||
| Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients | NCT02583191 | Venous Thromboe... Cancer | Rivaroxaban low-molecular h... | 18 Years - | AIO-Studien-gGmbH | |
| Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) | NCT03090880 | Venous Thromboe... Lung Neoplasm | Tinzaparin Sodi... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer | NCT01803022 | Venous Thromboe... | 18 Years - | LEO Pharma | ||
| Anticoagulation in Patients With Venous Thromboembolism and Cancer | NCT04618913 | Neoplasms Embolism | Apixaban Rivaroxaban Edoxaban Dabigatran VKA LMWH | 18 Years - | Pfizer | |
| VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy | NCT05920343 | Venous Thromboe... Urologic Cancer | Rivaroxaban 10 ... Placebo control | 18 Years - | Ottawa Hospital Research Institute | |
| Multi-Center Human Alert Trial to Prevent DVT and PE | NCT00409136 | Pulmonary Embol... Deep Vein Throm... Cancer Surgery | Human Alert | 18 Years - | Brigham and Women's Hospital | |
| Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism | NCT02017743 | Venous Thromboe... | 18 Years - | Trio Grup Clinical Research | ||
| Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection | NCT03115541 | Venous Thromboe... Thoracic Surger... Esophageal Canc... | 18 Years - | McMaster University | ||
| Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia | NCT03195010 | Acute Biphenoty... Acute Lymphobla... Acute Myeloid L... B-Cell Non-Hodg... Chronic Lymphoc... Chronic Myeloge... Hematologic and... Hematopoietic C... Myelodysplastic... Primary Myelofi... Secondary Myelo... T-Cell Non-Hodg... Thrombocytopeni... Venous Thromboe... | Platelet Transf... Platelet Transf... | 18 Years - | Fred Hutchinson Cancer Center | |
| Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO | NCT04846556 | Venous Thromboe... Cancer | data collection | 18 Years - | Centre Hospitalier Universitaire de Saint Etienne | |
| Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma | NCT02958969 | Venous Thromboe... Multiple Myelom... | Apixaban | 18 Years - | Dana-Farber Cancer Institute | |
| Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer | NCT00660205 | Thrombosis Deep Venous Thr... Pulmonary Embol... Venous Thromboe... Pancreas Cancer Esophagus Cance... Gastric Cancer | 15 Years - 85 Years | University of Aarhus | ||
| Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer | NCT05240508 | Venous Thromboe... | 18 Years - | University of Vermont | ||
| The Roles of Tissue Factor in Malignant Gliomas | NCT00201903 | Venous Thromboe... Brain Tumors | 18 Years - | Ontario Clinical Oncology Group (OCOG) | ||
| Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer | NCT00660205 | Thrombosis Deep Venous Thr... Pulmonary Embol... Venous Thromboe... Pancreas Cancer Esophagus Cance... Gastric Cancer | 15 Years - 85 Years | University of Aarhus | ||
| Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery | NCT01444612 | Thrombosis, Ven... | dalteparin enoxaparin fondaparinux unfractionated ... | 18 Years - | GlaxoSmithKline | |
| Long-term Active Surveillance Study for Oral Contraceptives (LASS) | NCT00676065 | Arterial Thromb... Venous Thromboe... Breast Cancer | - | Center for Epidemiology and Health Research, Germany | ||
| The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery | NCT01267305 | Lung Neoplasms Esophageal Neop... Venous Thromboe... | Fondaparinux Nadroparin Calc... Nadroparin Calc... | 18 Years - | Shanghai Zhongshan Hospital | |
| Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy | NCT02366871 | Gynecologic Can... Venous Thromboe... | Oral apixaban Subcutaneous en... | 18 Years - 89 Years | University of Colorado, Denver | |
| A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism | NCT03240120 | Venous Thromboe... Deep Vein Throm... Pulmonary Embol... | Dabigatran etex... Tinzaparin | 18 Years - | The University of Hong Kong | |
| Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban | NCT03214172 | Venous Thromboe... | Rivaroxaban (Xa... | 18 Years - | Bayer | |
| The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery | NCT01267305 | Lung Neoplasms Esophageal Neop... Venous Thromboe... | Fondaparinux Nadroparin Calc... Nadroparin Calc... | 18 Years - | Shanghai Zhongshan Hospital | |
| LIFE - Lung Cancer, Immunotherapy, Frailty, Effect | NCT03870464 | Non-small Cell ... Quality of Life Brain Metastase... Venous Thromboe... | CT-scans extend... MRI scan of the... Prospective reg... Quality of Life... | 18 Years - | University of Southern Denmark | |
| Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer | NCT01345773 | Gastric Cancer Venous Thromboe... Postoperative P... | Gastric surgery | 20 Years - | Seoul National University Bundang Hospital | |
| A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients | NCT00876915 | Venous Thromboe... Pulmonary Embol... | dalteparin inje... | 18 Years - | University of Rochester | |
| Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer | NCT03045406 | Venous Thromboe... | Apixaban Dalteparin | 18 Years - | Fadoi Foundation, Italy | |
| Thrombosis in Patients With Multiple Myeloma in an University Medical Center | NCT05541978 | Multiple Myelom... Venous Thromboe... Arterial Thromb... | Multiple myelom... | - | University Medical Center Groningen | |
| Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma | NCT02958969 | Venous Thromboe... Multiple Myelom... | Apixaban | 18 Years - | Dana-Farber Cancer Institute | |
| Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients | NCT00629447 | Primary Brain T... | Innohep | 18 Years - | Duke University | |
| Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment | NCT04744688 | Peritoneal Meta... Peritoneal Carc... Colorectal Neop... Intestinal Neop... Cytoreductive S... Venous Thromboe... Bleeding Laparoscopic Su... Coagulation Surgical Proced... Postoperative C... Laparoscopy Minimally Invas... Surgical Oncolo... | 18 Years - | University of Aarhus | ||
| Cancer-related Thromboembolic Disease | NCT02785757 | Adenocarcinoma | Thrombin Genera... | 18 Years - | Hospices Civils de Lyon | |
| Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans | NCT00925808 | Cancer Venous Thromboe... | Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism | NCT02585713 | Cerebral Vein T... Deep Vein Throm... Gonadal Thrombo... Hepatic Thrombo... Malignant Neopl... Mesenteric Thro... Metastatic Mali... Portal Vein Thr... Pulmonary Embol... Renal Vein Thro... Splenic Thrombo... Venous Thromboe... | Apixaban Dalteparin Questionnaire A... | 18 Years - | Academic and Community Cancer Research United | |
| An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism) | NCT05461807 | Treatment of Ve... Venous Thromboe... Cancer | Rivaroxaban (Xa... Apixaban | 18 Years - | Bayer | |
| Venous Thromboembolism in Primary Pancreatic Tumour Resection | NCT05964621 | Venous Thromboe... Pancreatic Canc... Pancreatic Duct... | 18 Years - | University of Thessaly | ||
| Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung | NCT02853188 | Cancer of Lung | venous thromboe... | 18 Years - | Hopital Foch | |
| Tumor-educated Platelets in Venous Thromboembolism | NCT02739867 | Neoplasms Venous Thromboe... | 40 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | ||
| Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism | NCT01602445 | Venous Thromboe... Deep-Vein Throm... Pulmonary Embol... Cancer | 18 Years - | Ottawa Hospital Research Institute | ||
| Venous Thromboembolism Prevention in Outpatients With Glioma | NCT05683808 | Glioblastoma Astrocytoma Venous Thromboe... | Apixaban | 18 Years - | University of Vermont Medical Center | |
| Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus | NCT03083782 | Venous Thromboe... Pharmacokinetic... Healthy | Apixaban alone Cyclosporine Tacrolimus Apixaban Apixaban | 18 Years - 55 Years | Thomas Jefferson University | |
| A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use | NCT02922543 | Multiple Myelom... | 18 Years - | Celgene | ||
| PREvention of VENous ThromboEmbolism Following Radical Prostatectomy | NCT03006562 | Prostate Cancer Venous Thromboe... Lymphocele Afte... Deep Venous Thr... Pulmonary Embol... | Subcutaneous He... | 18 Years - 100 Years | Johns Hopkins University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
